Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
JAMA Health Forum. 2021 Dec 3;2(12):e213937. doi: 10.1001/jamahealthforum.2021.3937. eCollection 2021 Dec.
This article examines the budgetary implications of high-priced accelerated approval drugs by estimating Medicare spending on these drugs from 2015 through 2019.
本文通过估算 2015 年至 2019 年医疗保险对这些药物的支出,考察了高价加速审批药物的预算影响。